Eccogene to Present Preclinical Data of Small Molecule Amylin and Calcitonin Receptor Agonist ECC1542 at ObesityWeek® 2026
Poster presentation will highlight the preclinical profile of ECC1542 and its potential for treating obesity and associated comorbidities Poster presentation will highlight the preclinical profile of ECC1542 and its potential for treating obesity and associated comorbidities
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


